Nutrien Stock Up 62% in a Year but Reddit Traders Are Still Bearish

Nutrien reported Q4 adjusted EPS of $0.83 versus a $0.92 consensus (a $0.09 miss) despite record potash sales of 14.25m tonnes in 2025 and full-year free cash flow of ~$2.002bn. Shares are up ~23% YTD and ~62% over the past year while Reddit sentiment sits bearish at 32/100; Jefferies raised its PT to $96 on geopolitical-driven fertilizer price spikes while UBS downgraded to Sell, and consensus target is near $78. Potash benchmark prices are ~13% higher YoY with Brazil spot near $375/tonne, forward P/E ~12x vs trailing 16x, and near-term uncertainty from a phosphate strategic review plus a Colorado class-action price‑fixing suit.

Analysis

Market pricing currently embeds a geopolitical premium and a near-term supply tightness narrative; the non-obvious leverage is how that premium amplifies short-term capital allocation decisions across Nutrien’s value chain. Distributors and crop-input retailers with thin inventories will accelerate purchases into any sustained price spike, lengthening the cycle’s positive feedback for several quarters but simultaneously increasing downstream exposure to sudden price reversals if shipping or trade routes normalize.

The single largest asymmetric risk is regulatory: a DOJ-linked class action is not just a cash risk but a credibility shock that could force more transparent, lower-frequency pricing and erase the current pricing stickiness. That outcome would manifest over 6–24 months and likely compress multiples disproportionately versus a cyclical softening because it changes the structural margin profile rather than just a one-off price move.

Analyst/retail positioning divergence creates tactical opportunities. Consensus targets and weak retail sentiment imply limited upside absent a sustained geopolitical premium, but the phosphate strategic review is a latent binary that could rerate the stock if management executes a carve-out or sale—this is a 3–12 month catalyst that markets tend to underprice until formal announcements. Conversely, if potash prices mean-revert within a quarter (a plausible path if logistical premiums unwind), expect earnings revisions to accelerate and the stock to underperform peers with lower potash exposure.

Key Decisions for Investors

• Long-duration call spread on NTR (buy Jan-2027 1x, sell Jan-2028 higher strike) — entry on any intraday >6% pullback from current levels. Rationale: asymmetric upside to a sustained geopolitical premium or positive outcome from the phosphate review; max loss = premium paid, target 2x payoff if premium persists for 12+ months.
• Pair trade: long NTR / short MOS (equal-dollar exposure, 6–12 month horizon) — use 10% stop on either leg. Rationale: isolates company-specific upside from strategic review and operational execution while hedging commodity-price beta; expected neutral market movement but positive idiosyncratic skew to Nutrien if review progresses.
• Protective put spread on NTR (buy 6–9 month OTM put, sell lower strike put) ahead of any material regulatory or review milestones — cost-effective downside insurance with defined max loss. Rationale: hedges DOJ/class-action tail risk that would compress multiples beyond cyclical reversion; preserves upside while capping hedging cost to a fraction of position size.
• Event-capture credit: sell covered calls (1–3 month) against core NTR exposure after positive announced milestones on the phosphate review to monetize the short-term volatility pop. Rationale: captures immediate premium when a binary fills in without relinquishing long exposure to longer-dated upside; acceptable if willing to cap upside at strike.